Covid end aims to create a global library of living systematic reviews. The group is now working out its longer term strategy, which includes a priority list for living evidence syntheses as the world moves into a recovery phase. Grimshaw: 'You'll get more bang for the buck if in selected areas you invest in living reviews'
A deluge of trials has stress-tested the systems that produce evidence.
Around the world, researchers have raced to test therapies to treat COVID-19. The speed and urgency of this task has revealed both the weaknesses in the collection and use of research-based evidence, and how well-run trials have helped save lives.
This is an audio version of our feature: How COVID broke the evidence pipeline
Hosted on Acast. See acast.com/privacy for more information.